Overview

Crossover Comparison of Two Gadolinium Contrast Agents for Use With MRA of Carotid, Renal and Peripheral Arteries

Status:
Completed
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
To compare two gadolinium contrast agents in terms of global paired diagnostic preference (primary endpoint) for the assessment of contrast-enhanced MR Angiography of the carotid, renal/abdominal and peripheral arteries
Phase:
Phase 3
Details
Lead Sponsor:
Bracco Diagnostics, Inc